twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2007
vol. 109
 
Share:
Share:
abstract:
Original paper

Inhtravitreal triamcinolone acetonide injections in the treatment of cystoid macular edema due to the central or branch retinal vein occlusion

Anna Lubczyńska
1
,
Jarosław Kocięcki
1

  1. Katedra i Klinika Okulistyki Akademii Medycznej w Poznaniu
Klinika Oczna 2007, 109 (2): 169-172
Online publish date: 2007/06/12
View full text Get citation
 
Purpose
To appoint the most adequate follow-up parameter and to find the most reliable scheme of intravitreal TA injections in CME treatment in the course of CRVO and BRVO.

Material and methods
18 eyes treated with intravitreal injection of 4 mg (in 0.1 ml) of crystalline TA.

Results
There was improvement of BCVA for distance noticed in 38.9% of eyes and for near in 44.4% of cases. There was statistically significant difference in retinal thickness outcomes measured at baseline and at the end of the follow-up by both OCT and RTA. No correlation of BCVA changes and retinal thickness changes measured in OCT and RTA was found

Conclusions
The intravitreal TA injections should be considered as an effective method. Foveal morphology and thickness analysis performed by OCT is the most adequate method in follow-up monitoring of intravitreal TA injections in CME treatment in non-ischemic CRVO or BRVO. Central retinal thickness measured by RTA and FA changes analysis are alternative monitoring methods. Dosage of 4mg TA in 0.1 ml seems to be sufficient. In cases of CME recurrence of subsequent intravitreal injection in the first 6 month after initial injection seems to be unnecessary.

keywords:

central retinal vein occlusion, branch retinal vein occlusion, cystoid macula edema, triamcinolone acetonide

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.